The American Diabetes Association and Endocrine Society emphasize that any substance affecting appetite, nausea, or blood sugar perception should be disclosed and discussed before starting GLP-1 therapy
Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF
Fatigue is a clinically relevant concern for GLP-1 users because it can affect treatment adherence and quality of life
Conserver dans un endroit frais et sec
Individuals may also experience low blood sugar levels, especially if combined with other medications
Galactomyces Ferment Filtrate, Glycerin, 1,2-Hexanediol, Niacinamide, Water, Methylpropanediol, 2,3-Butanediol, Diphenyl Dimethicone, Bis-PEG-18 Methyl Ether Dimethyl Silane, Triethylhexanoin, C12-14 Alketh-12, Hydroxyacetophenone, Hydrogenated Lecithin, Polyglyceryl-10 Oleate, Sodium Citrate, Ethylhexylglycerin, Butylene Glycol, Citric Acid, Adenosine, Disodium EDTA, Oryza Sativa (Rice) Bran Extract, Caprylyl Glycol, Glutathione, 3-O-Ethyl Ascorbic Acid, Tocopherol, Portulaca Oleracea Extract, Betaine, Hydrolyzed Hyaluronic Acid, Ulmus Davidiana Root Extract, Amaranthus Caudatus Seed Extract, Oryza Sativa (Rice) Bran Oil, Propanediol, Ceramide NP, Phytosphingosine, Saccharomyces/Rice Ferment Filtrate, Acetyl Hexapeptide-1